CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte function.
Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte function.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
TIL(肿瘤浸润淋巴细胞)常因逐渐分化为“耗竭”状态而无法抑制肿瘤生长。组织驻留记忆T细胞(T RM)在健康组织中可维持数年的抗感染保护,而含有具有T RM特征的TIL的患者肿瘤与更好的预后相关。对T细胞群体进行的蛋白质组学和转录组学分析发现,蛋白质稳态是区分T RM和祖细胞耗竭型TIL与终末耗竭型TIL的重要因素,包括E3泛素连接酶NEURL3、RNF149和WSB1的缺失,且尽管蛋白酶体活性正常,未折叠蛋白仍发生蓄积。在T细胞中强制表达这些连接酶可维持干细胞样TCF1+细胞群,并改善肿瘤和慢性感染中的功能;而缺失则损害TIL,并在急性感染期间改变T细胞分化。持续表达连接酶可挽救TIL中未折叠蛋白的蓄积,并改善临床前模型中的免疫治疗结局,这凸显了蛋白质稳态在TIL功能中的关键作用,并指明了一条推进癌症免疫治疗的有前景的途径。
Tumor-infiltrating lymphocytes (TIL) often fail to restrain tumor growth due to progressive differentiation into an "exhausted" state. Tissue-resident memory T cells (T RM ) maintain protection from infection for years in healthy tissues, and patient tumors that contain TIL with T RM features are associated with better prognosis. Proteomic and transcriptomic profiling of T cell populations identified proteostasis as a significant factor distinguishing T RM and progenitor-exhausted TIL from terminally exhausted TIL, including loss of E3 ubiquitin ligases NEURL3, RNF149, and WSB1, with accumulation of unfolded proteins despite functional proteasome activity.
Enforced expression of these ligases in T cells preserved stem-like TCF1 + populations and improved function in tumors and chronic infection, whereas deficiency impaired TIL and altered T cell differentiation during acute infection. Sustained ligase expression rescued the accumulation of unfolded proteins in TIL and improved immunotherapy outcomes in preclinical models, underscoring the critical role of proteostasis in TIL function and highlighting a promising avenue for advancing cancer immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。